0

In Vivo Attenuation and Genetic Evolution of a ST247-SCCmecI MRSA Clone After 13 Years of Pathogenic Bronchopulmonary Colonization in a Patient With Cystic Fibrosis: Implications of the Innate Immune Response

E López-Collazo, T Jurado, J de Dios Caballero, M Pérez-Vázquez, A Vindel, E Hernández-Jiménez, J Tamames, C Cubillos-Zapata, M Manrique, R Tobes, L Máiz, R Cantón, F Baquero, R Del Campo

Mucosal Immunol. 2015 Mar;8(2):362-71.

PMID: 25118167

Abstract:

Methicillin-resistant Staphylococcus aureus (MRSA) causes chronic pulmonary infections in patients with cystic fibrosis (CF). This study tracks the 13-year evolution (1996-2009) of a single MRSA clone in a male patient with CF, evaluating both the host immunogenic response and the microbial variations. Whole-genome sequencing was performed for the initial (CF-96) and evolved (CF-09) isolates. The immunogenicity of CF-96 and CF-09 was evaluated by incubation with innate immune cells from healthy volunteers. We also studied the patient's innate immune response profile, cytokine production, expression of triggering receptor expressed on myeloid cells-1 (TREM-1), and phagocytosis. A total of 30 MRSA ST247-SCCmecI-pvl(-) isolates were collected, which evidenced a genome size reduction from the CF-96 ancestor to the evolved CF-09 strain. Up to six changes in the spa-type were observed over the course of the 13-year evolution. Cytokine production, TREM-1 expression, and phagocytosis were significantly lower for the healthy volunteer monocytes exposed to CF-09, compared with those exposed to CF-96. Patient monocytes exhibited a reduced inflammatory response when challenged with CF-09. Genetic changes in MRSA, leading to reduced immunogenicity and entry into the refractory state, may contribute to the attenuation of virulence and efficient persistence of the bacteria in the CF lung.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP1356497910 ST247 ST247 1356497-91-0 Price
qrcode